1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

InnoPharmaScreen Inc.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2009

Location

South Korea

Primary Industry

Pharmaceuticals

About

Founded in 2009 and based in Incheon, South Korea, InnoPharmaScreen Inc. operates as a developer of a protein chip-based and AI-aided drug discovery platform. As of 2020, it completed two rounds of financing. The company has developed new drug candidates through the new drug development platform and is conducting clinical trials on reserved pipelines such as asthma therapeutics and non-small cell lung cancer therapeutics. At present, it has 2 clinical and 3 nonclinical pipelines.
Current Investors
AJU IB Investment, Magna Investment, KDB Capital

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.innopharmascreen.com
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo